Moradigaravand Danesh, Martin Veronique, Peacock Sharon J, Parkhill Julian
Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, United Kingdom.
British Society for Antimicrobial Chemotherapy, Birmingham, United Kingdom.
mBio. 2017 Feb 21;8(1):e01976-16. doi: 10.1128/mBio.01976-16.
is a human commensal and opportunistic pathogen that has become a leading causative agent of hospital-based infections over the past few decades. The emergence and global expansion of hypervirulent and multidrug-resistant (MDR) clones of have been increasingly reported in community-acquired and nosocomial infections. Despite this, the population genomics and epidemiology of MDR at the national level are still poorly understood. To obtain insights into these, we analyzed a systematic large-scale collection of invasive MDR isolates from hospitals across the United Kingdom and Ireland. Using whole-genome phylogenetic analysis, we placed these in the context of previously sequenced populations from geographically diverse countries and identified their virulence and drug resistance determinants. Our results demonstrate that United Kingdom and Ireland MDR isolates are a highly diverse population drawn from across the global phylogenetic tree of and represent multiple recent international introductions that are mainly from Europe but in some cases from more distant countries. In addition, we identified novel genetic determinants underlying resistance to beta-lactams, gentamicin, ciprofloxacin, and tetracyclines, indicating that both increased virulence and resistance have emerged independently multiple times throughout the population. Our data show that MDR isolates in the United Kingdom and Ireland have multiple distinct origins and appear to be part of a globally circulating population. is a major human pathogen that has been implicated in infections in healthcare settings over the past few decades. Antimicrobial treatment of infections has become increasingly difficult as a consequence of the emergence and spread of strains that are resistant to multiple antimicrobials. To better understand the spread of resistant , we studied the genomes of a large-scale population of extensively antimicrobial-resistant in the United Kingdom and Ireland by utilizing the fine resolution that whole-genome sequencing of pathogen genomes provides. Our results indicate that the population is highly diverse and that, in some cases, resistant strains appear to have spread across the country over a few years. In addition, we found evidence that some strains have acquired antimicrobial resistance genes independently, presumably in response to antimicrobial treatment.
是一种人体共生菌和机会致病菌,在过去几十年里已成为医院感染的主要病原体。高毒力和多重耐药(MDR)克隆的出现及其在全球范围内的传播,在社区获得性感染和医院感染中越来越多地被报道。尽管如此,国家层面上MDR的群体基因组学和流行病学仍知之甚少。为了深入了解这些情况,我们分析了从英国和爱尔兰各地医院系统大规模收集的侵袭性MDR分离株。通过全基因组系统发育分析,我们将这些分离株置于来自不同地理区域国家的先前测序的群体背景中,并确定了它们的毒力和耐药决定因素。我们的结果表明,英国和爱尔兰的MDR分离株是一个高度多样化的群体,来自全球的系统发育树,代表了多个近期的国际引入,主要来自欧洲,但在某些情况下来自更远的国家。此外,我们确定了对β-内酰胺类、庆大霉素、环丙沙星和四环素耐药的新遗传决定因素,表明毒力增加和耐药在整个群体中多次独立出现。我们的数据表明,英国和爱尔兰的MDR分离株有多个不同的起源,似乎是全球传播的群体的一部分。是一种主要的人类病原体,在过去几十年里一直与医疗环境中的感染有关。由于对多种抗菌药物耐药的菌株的出现和传播,对感染的抗菌治疗变得越来越困难。为了更好地了解耐药的传播情况,我们利用病原体基因组全基因组测序提供的高分辨率,研究了英国和爱尔兰大量广泛耐药的群体的基因组。我们的结果表明,群体高度多样化,在某些情况下,耐药菌株似乎在几年内传遍了全国。此外,我们发现有证据表明,一些菌株独立获得了抗菌耐药基因,可能是对抗菌治疗的反应。